Clinical Trial Update: Study of Red Bull™ Sugar-Free Drink for Reduction of Fatigue in Prostate Cancer Patients Receiving LHRH Agonist Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating whether Red Bull Sugar-Free Drink reduces fatigue in prostate cancer patients receiving LHRH agonist therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Red Bull Sugar-Free Drink

Snippet

Sponsor: University Health Network, Toronto | Conditions: Fatigue | Phase 2 | Status: COMPLETED